Raquel Aguiar-Ibáñez
9PUBLICATIONS
23CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Apr 10, 2026
Extrapolation of Time-to-Event Survival Outcomes of Histology-Independent Therapies Using a Bayesian Hierarchical Model.Jan Mikelson, Richard Birnie, Grant McCarthy
|Feb 07, 2026
Rationale and recommendations for improving early-stage oncology diagnosis, treatment, and access.R Aguiar-Ibáñez, D Goldschmidt, Z Y Zhou
|Mar 25, 2025
A US Survey Across Seven Early-Stage Cancers Assessing the Humanistic Burden of Recurrence on Patients and Caregivers.Raquel Aguiar-Ibáñez, Kelly McQuarrie, Ana Martinez
|Oct 19, 2024
Differences Between Intravenous and Subcutaneous Modes of Administration in Oncology from the Patient, Healthcare Provider, and Healthcare System Perspectives: A Systematic Review.Raquel Aguiar-Ibáñez, Iain Fotheringham, Lalith Mittal
|Jan 31, 2024
Cost-effectiveness of pembrolizumab for previously treated MSI-H/dMMR solid tumours in the UK.Grant McCarthy, Kate Young, Matthew Madin-Warburton
|Mar 25, 2022
Systematic literature review and network meta-analysis of pembrolizumab versus other interventions for previously untreated, unresectable or metastatic, MSI-high or MMR-deficient CRC.He Jin, Mayur Amonkar, Raquel Aguiar-Ibáñez
Pageof 2
Frequent Collaborators
2 joint publications
Jan Mikelson
2 joint publications
Kate Young
2 joint publications
Mayur Amonkar
2 joint publications
Grant McCarthy
1 joint publications
Gianluca Baio
1 joint publications
O Ciani
1 joint publications
A Arunachalam
1 joint publications
A Roediger
1 joint publications
C M Black
1 joint publications
Miranda Cooper
